Topic List : Cancer
Grants awarded for cancer immunotherapy
The Parker Institute for Cancer Immunotherapy at Stanford hands out its first grants to researchers who hope to translate scientific discoveries into new therapies for cancer patients.
Antibody effective against brain tumors
Antibodies against the CD47 “don’t eat me” signal were shown in mice to be a safe and effective way to target five kinds of pediatric brain tumors, according to Stanford researchers.
Podcast: The relationship between science and magic
When he’s not developing computer models to improve cancer detection, Parag Mallick, PhD, is juggling fire, walking on stilts or mastering card tricks. In this podcast, he talks about how he became a member of a professional performance troupe and the relationship between science and magic.
Heart-damaging chemo drugs ranked
Stanford researchers have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs.
Algorithm can identify skin cancer
In the hope of creating better access to medical care, Stanford researchers have trained an algorithm to diagnose skin cancer.
Many breast cancer patients ‘undertested’
Physicians often fail to recommend genetic testing to breast cancer patients at high risk for cancer-associated mutations. Improving access to genetic counseling about the testing process and results is a key priority.
Tumor rejection requires coordinated immune response
Effective anti-tumor activity requires a systemic, rather than only a local, immune response at the tumor site. A Stanford study may help clinicians pinpoint why only some cancer patients respond to immunotherapies.
GPS for tracking immune cells
In the culmination of a 10-year-long effort, researchers have demonstrated the first visualization of human immune cells as they track down brain tumor cells in living patients.
Benefit shown in a subgroup of patients
Glioblastoma patients with a high degree of vascularization of their tumors were found to have benefited from a treatment previously deemed ineffective, a new Stanford study shows.
Blood test to evaluate lung cancer tumors
A technique developed at Stanford for detecting the genetic profiles of tumor cells sifted from the bloodstream could offer a valuable tool for the clinic and the lab.